Výsledky vyhledávání - "Mikhail V. Shaidorov"

Akademický článek

The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study

Publikováno v: Современная онкология, Vol 22, Iss 1, Pp 53-59 (2020)

The article presents the experience of 19 Russian medical institutions on the use of eribulin in combination with trastuzumab in various treatment lines of metastatic HER2+ breast cancer in routine clinical practice. Aim. The main objective of thi

Externí odkaz: https://doaj.org/article/348c12ae10644482a51e5fd30b93fd11

Zobrazit plný text záznamu

Akademický článek

The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience

Autor: Irina V Kolyadina, Irina S Bulavina, Vladislav V Petkau, Natalia V Strakhova, Vera A Gorbunova, Elena I Kovalenko, Liudmila V Manziuk, Elena V Artamonova, Liudmila G Zhukova, Larisa V Bolotina, Inna P Gan'shina, Tatiana Iu Semiglazova, Aleksei G Manikhas, Natalia A Raevskaia, Ilia M Itkin, Svetlana V Khokhlova, Dmitrii V Filonenko, Viktor E Gol'dberg, Natalia O Popova, Dmitrii M Ponomarenko, Valentina E Shikina, Liubov I Vladimirova, Natalia M Tikhanovskaia, Elena V Karabina, Guzel Z Mukhametshina, Alfiia I Khasanova, Sufiia Z Safina, Mikhail V Shaidorov, Andrei E Orlov, Iuliia V Kostalanova, Natalia V Levchenko, Mikhail A Osipov, Tatiana V Karandeeva, Irina V Evstigneeva, Igor S Chernov, Dzheims Dzh Kolokolov, Anton Iu Povyshev, Alina S Shatokhina, Elena M Cherniakova, Oksana N Shkodenko, Evgeniia S Kuz'mina

Publikováno v: Современная онкология, Vol 21, Iss 2, Pp 17-24 (2019)

Aim. Eribulin is an active cytostatic, associated with a wide range of mechanisms of antitumor effects, but eribulin efficiency and safety in patients with breast cancer (BC), associated with cerebral metastases are still poorly understood. Materials

Externí odkaz: https://doaj.org/article/5f21fe71ca7c49f6a857b2579dfadccd

Zobrazit plný text záznamu

Akademický článek

Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia

Autor: Vera A Gorbunova, Irina V Kolyadina, Elena I Kovalenko, Liudmila V Manziuk, Elena V Artamonova, Liudmila G Zhukova, Larisa V Bolotina, Tat'iana Iu Semiglazova, Aleksei G Manikhas, Natal'ia A Raevskaia, Il'ia M Itkin, Dmitrii V Filonenko, Larisa A Zhilyaeva, Viktor E Gol'dberg, Natal'ia O Popova, Dmitrii M Ponomarenko, Valentina E Shikina, Irina R Suslova, Olga V Romanchuk, Dmitrii V Kozlov, Ali-Dzarakhmat S Rzaev, Vasilii V Marfutov, Irina I Andreiashkina, Liubov' I Vladimirova, Irina S Mitashok, Natal'ia M Tikhanovskaia, Elena V Karabina, Guzel' Z Mukhametshina, Al'fiia I Khasanova, Sufiia Z Safina, Mikhail V Shaidorov, Dmitrii A Morozov, Elena P Prokof'eva, Liudmila V Kramskaia, Tat'iana V Karandeeva, Irina V Evstigneeva, Elena G Ovchinnikova, Tat'iana P Klement'eva, Olga V Khrupalo, Elena V Tiuvinova, Viktor M Sherstnev, Igor' S Chernov, Dzheims Dzh Kolokolov, Elena A Gaisina, Natal'ia V Levchenko, Viacheslav A Chubenko, Anton Iu Povyshev, Inna V Iudina, Liudmila V Vorotilina, Tat'iana V Andreeva, Garnik S Tumanian, Anton E Koziakov, Liudmila A Gil'mutdinova, Mikhail A Osipov, Alina S Shatokhina, Alena A Vazhenina, Angelina S Chichkanova, Vladimir I Vladimirov, Aleksandr N Ivanov, Anna S Belokhvostova, Elena M Cherniakova, Elena A Tul'china, Svetlana A Maklashova, Oksana N Shkodenko, Iuliia V Kostalanova, Anna V Tarasova, Evgeniia S Kuz'mina

Publikováno v: Современная онкология, Vol 21, Iss 1, Pp 12-23 (2019)

Aim. The aim of the study is to examine the efficacy and safety of eribulin in HER2-negative metastatic breast cancer (BC) in Russian clinical practice. Materials and methods. The analysis included 459 patients with advanced BC from 44 federal and mu

Externí odkaz: https://doaj.org/article/fab8f79eb72a4ebeb4af3ca5e29be2e9

Zobrazit plný text záznamu